Norway: rettet emisjon — private placements for Oslo Børs and Euronext Growth Oslo issuers

A listed company in Norway can raise a convertible loan priced against a future market price at each conversion and can draw a standby equity facility under a board authorisation. The rettet emisjon (directed issue) is more than 90% of issue volume on Oslo Børs-operated venues, which makes Norway the most placement-friendly market in the region. The binding rule is equal treatment, not capacity.

Key takeaways

• The board authorisation is the enabling document, and it is capped. Section 10-14 of the Public Limited Liability Companies Act lets the general meeting authorise the board to increase the share capital for no more than two years at a time, with the aggregate nominal value issuable held within half of the share capital registered when the authorisation was registered. Whether the board may also disapply pre-emption rights has to be stated in the authorisation itself.
• A konvertibelt lån is a Chapter 11 instrument. It is registered in the Register of Business Enterprises, after which the holder converts without a further corporate step. Nothing in the Act fixes its conversion price.
• Equal treatment binds where a percentage cap would not. Norway sets no fixed general-mandate ceiling. Section 5-14 of the Securities Trading Act requires equal treatment of holders, and Oslo Børs enforces it against directed issues.
• A repair issue is the normal remedy, not a courtesy. Excluded shareholders are offered the same price afterwards, and the key dates have to be announced separately.
• Euronext Growth Oslo runs on its own rule book. It is an MTF, so section 5-14 does not apply directly; equivalent equal-treatment provisions sit in the growth-market rules instead.

How a Norwegian placement actually runs

The Oslo model is built around the evening. The board resolves to launch after the close, the book is built overnight through a manager, pricing and allocation are settled before the market opens, and the transaction is announced in the pre-open window. The preparation happens weeks earlier: a live authorisation of the right size, a manager engaged, the equal-treatment analysis documented.

The tranche split is the piece foreign issuers most often miss. Where the new shares would breach the prospectus exemption for shares fungible with those already listed, the placement is split into a first tranche admitted immediately and a second that settles once a prospectus is approved. That threshold is moving: the EU Listing Act raises it from 20% to 30% over 12 months, and the Norwegian implementation date is not settled, so size against the rule in force on the day.

What the board can do without a general meeting

The Public Limited Liability Companies Act lets the general meeting delegate the capital increase to the board, subject to a maximum amount and a two-year term. The Norwegian Code of Practice for Corporate Governance goes further, recommending authorisations run only to the next annual general meeting.

Two details decide whether the board can use it on the night. Does the authorisation expressly permit the disapplication of pre-emption rights? One that is silent does not permit a directed issue. And is the remaining headroom enough for the whole raise, including the repair issue and any shares reserved for a convertible?

Equal treatment is the constraint that bites

Section 5-14 of the Securities Trading Act requires an issuer admitted to a Norwegian regulated market to treat holders equally, and prohibits any deviation that is not objectively justified in the interests of the issuer and its shareholders. Oslo Børs enforces that rule directly. In practice the board minute has to record why a directed issue was chosen over a rights issue: speed, certainty of funding, market risk over a subscription period, and the discount.

The exchange also expects to be told. Oslo Børs requires issuers to supply information about a share capital increase through its issuer portal before the new shares are admitted, which is a real gate on the settlement timetable rather than a formality.

Treat the regime as under supervisory attention rather than settled. Finanstilsynet has published findings on how investment firms advise issuers on the choice of issue and how the exchange monitors equal treatment, and says a firm assisting an issuer must give balanced information and advice on that choice.

Konvertibelt lån: pricing, and the authorisation ceiling

A konvertibelt lån, convertible loan, is raised under Chapter 11 of the allmennaksjeloven and registered in the Register of Business Enterprises, after which the holder converts without a further corporate step. Nothing in the Act fixes the conversion price when the loan is raised and no statutory maximum discount applies, so a price measured against a volume weighted average price at each conversion is a matter of contract rather than company law.

The ceiling is the authorisation. Section 10-14 provides that a styrefullmakt to increase the share capital may run for no more than two years at a time, that the nominal value issuable under it must be within half of the share capital registered when the authorisation was registered, and that the resolution must state expressly whether the pre-emptive right under section 10-4 may be set aside. Whether the same two limits govern a separate authorisation to raise a convertible loan under Chapter 11 was not confirmed here, and it is worth settling with Norwegian counsel before sizing the reservation.

Oslo Børs, Euronext Expand and Euronext Growth Oslo

Norway runs two regulated markets and one growth market. The venue matters more than the instrument.

Choosing between equity, a convertible and a facility

Norwegian boards reach for equity first, and for good reason: the placement machine works. Convertible structures earn their place where the raise is larger than the authorisation headroom, or where dilution is better deferred to a milestone. A convertible still consumes headroom for the underlying shares, so the reservation belongs in the authorisation itself.

Drawdown structures are rarer in Oslo than in London, but a committed equity facility suits a Euronext Growth issuer with a long development programme. Both sit on the instruments hub, and the arithmetic is in dilution and conversion mechanics. If the issuer is also United States listed, the resale analysis switches jurisdictions and Rule 144 governs.

Related reading

• All markets
• Denmark
• Iceland
• Equity facilities
• Check whether you qualify

Primary sources

• Lovdata — Public Limited Liability Companies Act, chapter 10 (board authorisations)
• Lovdata — Securities Trading Act, section 5-14 (equal treatment)
• Euronext Oslo Rule Book II — Issuer Rules
• Euronext Growth Oslo Rule Book, Part II
• Finanstilsynet — prospectuses

Financing a Norwegian issuer: frequently asked questions

Does a Norwegian private placement need a shareholder vote?

Usually not at the time of the placement. Most Oslo issuers carry a standing authorisation from the general meeting that lets the board resolve a capital increase and, where the authorisation says so, set aside pre-emption rights. That authorisation cannot run for more than two years. If it is exhausted or does not cover the disapplication, an extraordinary general meeting is required and the timetable changes completely.

What is a repair issue and when is one expected?

A repair issue is a subsequent offering to the shareholders excluded from the private placement, normally at the same subscription price and capped by reference to each holder's stake. It is the standard Norwegian answer to the equal-treatment problem a directed issue creates: a market and supervisory expectation rather than an automatic legal requirement. The key dates must be disclosed in a separate announcement.

How large can a Norwegian private placement be?

There is no fixed percentage cap in the listing rules. The practical ceiling is the headroom left in the registered board authorisation, the prospectus threshold for admitting the new shares to trading, and whether the board can justify the deviation from equal treatment on the day. That is a very different constraint from the fixed capacity limits used in Hong Kong, Singapore or Australia.

Are shares issued in a Norwegian placement freely tradable?

Norwegian law has no equivalent of the United States concept of restricted securities, so the new shares are ordinary shares once the capital increase is registered and recorded in the VPS. The gating item is admission to trading, which is why a placement is often split into tranches. A United States investor may still face resale restrictions under its own law.